Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Xenon Pharmaceuticals Inc. - Common Shares (NQ:XENE)

30.64 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 224
Open 30.64
Bid (Size) 12.34 (1)
Ask (Size) 41.50 (1)
Prev. Close 30.64
Today's Range 30.64 - 30.64
52wk Range 30.58 - 46.00
Shares Outstanding 63,562,303
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Xenon to Present at Stifel 2025 Virtual CNS Forum
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
Xenon Reports Fourth Quarter & Full Year 2024 Financial Results and Business Update
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire

Performance

YTD
-23.7%
-23.7%
1 Month
-14.4%
-14.4%
3 Month
-21.8%
-21.8%
6 Month
-24.1%
-24.1%
1 Year
-27.3%
-27.3%

More News

Read More
Earnings Scheduled For February 27, 2025
Via Benzinga
Xenon to Present at the 45th Annual TD Cowen Healthcare Conference
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
Earnings Scheduled For November 12, 2024
Via Benzinga
Earnings Preview: Xenon Pharmaceuticals
Via Benzinga
Xenon to Report Q4 and Full Year 2024 Financial Results on February 27, 2025
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
Xenon Outlines Key Corporate Milestone Opportunities for 2025
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
Xenon to Present at the 43rd Annual J.P. Morgan Healthcare Conference
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
Xenon Showcases New Long-Term Azetukalner Data from X-TOLE OLE Study in FOS at AES 2024
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
Xenon to Showcase New Long-Term Azetukalner Data at AES 2024
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
Xenon to Present at Upcoming Investor Conferences
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
Xenon Reports Q3 2024 Financial Results and Business Update
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
Xenon to Report Q3 2024 Financial Results on November 12, 2024
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
Xenon to Present at BofA Securities 2024 CNS Therapeutics Virtual Conference
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
Xenon Showcases Azetukalner Data at 15th European Epilepsy Congress
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
Xenon Expands Leadership Team with Matthew D. Ronsheim, Ph.D. as Chief Operating Officer
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
XENE Stock Earnings: Xenon Pharmaceuticals Misses EPS for Q2 2024
Via InvestorPlace
Xenon Reports Q2 2024 Financial Results and Business Update
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
Xenon to Report Q2 2024 Financial Results on August 8, 2024
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
Xenon Pharmaceuticals to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
Xenon Pharmaceuticals Presents Data from Phase 2 X-NOVA Clinical Trial of Azetukalner in Major Depressive Disorder at the American Society of Clinical Psychopharmacology 2024 Annual Meeting
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
XENE Stock Earnings: Xenon Pharmaceuticals Beats EPS for Q1 2024
Via InvestorPlace
Xenon Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
Xenon Pharmaceuticals to Present at the BofA Securities Health Care Conference 2024
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire

Frequently Asked Questions

Is Xenon Pharmaceuticals Inc. - Common Shares publicly traded?
Yes, Xenon Pharmaceuticals Inc. - Common Shares is publicly traded.
What exchange does Xenon Pharmaceuticals Inc. - Common Shares trade on?
Xenon Pharmaceuticals Inc. - Common Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Xenon Pharmaceuticals Inc. - Common Shares?
The ticker symbol for Xenon Pharmaceuticals Inc. - Common Shares is XENE on the Nasdaq Stock Market
What is the current price of Xenon Pharmaceuticals Inc. - Common Shares?
The current price of Xenon Pharmaceuticals Inc. - Common Shares is 30.64
When was Xenon Pharmaceuticals Inc. - Common Shares last traded?
The last trade of Xenon Pharmaceuticals Inc. - Common Shares was at 04/01/25 04:00 PM ET
What is the market capitalization of Xenon Pharmaceuticals Inc. - Common Shares?
The market capitalization of Xenon Pharmaceuticals Inc. - Common Shares is 1.95B
How many shares of Xenon Pharmaceuticals Inc. - Common Shares are outstanding?
Xenon Pharmaceuticals Inc. - Common Shares has 2B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.